Presentation is loading. Please wait.

Presentation is loading. Please wait.

Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven.

Published bySpencer Newman Modified over 5 years ago

Similar presentations

Presentation on theme: "Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven."— Presentation transcript:

1 Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven Klunker, PhD, Lavina R. Saggar, MSc, Vicki Seyfert-Margolis, PhD, Adam L. Asare, PhD, Thomas B. Casale, MD, Stephen R. Durham, MD, James N. Francis, PhD  Journal of Allergy and Clinical Immunology  Volume 120, Issue 3, Pages (September 2007) DOI: /j.jaci Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Schematic of the IgE-FAB assay.
Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Characterization of the FAB assay. A, Ragweed-specific IgE–containing serum (n = 3) and variable concentrations of ragweed allergen were preincubated for 1 hour at 37°C before addition to EBV-transformed B cells for 1 hour at 4°C. B, High ragweed-specific IgE–containing serum (n = 3) was serially diluted with assay buffer and incubated with 1 μg/mL allergen, as above. C, Indicator serum (n = 3) from patients with high ragweed-specific IgE was heat inactivated at 56°C for 30 minutes, and binding to B cells was compared with that of untreated serum in the assay, as above. D, B cells were pretreated with an anti-CD23 blocking antibody or isotype control antibody for 30 minutes at 4°C and used in the assay, as above. E, Equal volumes of immunotherapy serum were added to indicator serum and various allergen concentrations in the FAB assay. All data are shown as mean (± SE) percentages of B cells bound to allergen-IgE complexes. RW, Ragweed; IT, immunotherapy. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Assessment of serum inhibitory properties during the study. Inhibitory activity of serum was tested in the FAB assay, where binding of indicator serum alone was normalized to 100%. Data are shown as means ± SE. Differences between baseline measurements and other time points were assessed by using the Friedman nonparametric repeated-measures test (∗P < .05). Differences between placebo and immunotherapy groups were assessed by using a Mann-Whitney U test (†P < .05). IT, Immunotherapy; OM, omalizumab. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Comparison of inhibitory responses with either crude ragweed allergen extract or the major ragweed allergen Amb a 1 in the FAB assay within the 4 treatment groups (n = 3 per group). Data are shown as means ± SE. IT, Immunotherapy; OM, omalizumab. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Changes in allergen-specific IgG4 levels relative to pretreatment levels over the course of the study. Allergen-specific IgG4 levels were measured by means of ELISA. Individual data are shown, and differences between baseline measurements and time points were assessed by using the Friedman nonparametric repeated-measures test (∗P < .05, ∗∗P < .01, and ∗∗∗P < .001). IT, Immunotherapy; OM, omalizumab. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig 6 Assessment of serum inhibitory properties 18, 30, and 42 weeks after discontinuation of treatment. Inhibitory activity of the serum was tested in the FAB assay, where binding of indicator serum alone was normalized to 100%. Data are shown as means ± SE. Differences between groups were assessed by using the Mann-Whitney U test. P, Placebo; IT, immunotherapy; OM, omalizumab. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding  Sven."

Similar presentations

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.

Repeated low-dose intradermal allergen injection suppresses allergen-induced cutaneous late responses  Giuseppina Rotiroti, MD, Mohamed Shamji, PhD, Stephen.
Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies  Marija Geroldinger-Simic, MD, Thomas Zelniker,

Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies  Marija Geroldinger-Simic, MD, Thomas Zelniker,
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R

Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R
Modulation of basophil activity: A novel function of the neuropeptide α-melanocyte– stimulating hormone  Markus Böhm, MD, Mara Apel, Koji Sugawara, MD,

Modulation of basophil activity: A novel function of the neuropeptide α-melanocyte– stimulating hormone  Markus Böhm, MD, Mara Apel, Koji Sugawara, MD,
Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE  Eva-Maria Varga, MD, Fahima Kausar, MSc, Werner.

Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE  Eva-Maria Varga, MD, Fahima Kausar, MSc, Werner.
Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.

Ibrutinib, a Bruton’s tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil.
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences.

Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences.
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,

Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.

Differential cytokine induction by the human skin–associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control.
Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy  Raphaela.

Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy  Raphaela.
Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE- mediated hypersensitivity  Oliver T. Burton, PhD, Stephanie L. Logsdon,

Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE- mediated hypersensitivity  Oliver T. Burton, PhD, Stephanie L. Logsdon,
Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy  Julie Wang, MD,

Correlation of IgE/IgG4 milk epitopes and affinity of milk-specific IgE antibodies with different phenotypes of clinical milk allergy  Julie Wang, MD,
Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies 

Birch pollen immunotherapy results in long-term loss of Bet v 1–specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy  Robert A.

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy  Robert A.
Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge  Yee Ean Ong, MBBS, Andrew Menzies-Gow,

Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge  Yee Ean Ong, MBBS, Andrew Menzies-Gow,
Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies  Louisa K. James, PhD, Mohamed H. Shamji,

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies  Louisa K. James, PhD, Mohamed H. Shamji,
Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity  Jens Holm, PhD, Nicholas Willumsen,

Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity  Jens Holm, PhD, Nicholas Willumsen,

Similar presentations

Ads by Google